BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Amilca-Seba K, Sabbah M, Larsen AK, Denis JA. Osteopontin as a Regulator of Colorectal Cancer Progression and Its Clinical Applications. Cancers (Basel) 2021;13:3793. [PMID: 34359694 DOI: 10.3390/cancers13153793] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Li N, Zhu Q, Tian Y, Ahn KJ, Wang X, Cramer Z, Folkert IW, Yu P, Jou J, Adams-tzivelekidis S, Sehgal P, Mahmoud NN, Aarons CB, Roses RE, Thomas-tikhonenko A, Furth EE, Stanger BZ, Rustgi A, Haldar M, Katona BW, Tan K, Lengner CJ. Mapping and modeling human colorectal carcinoma interactions with the tumor microenvironment.. [DOI: 10.1101/2022.09.13.506996] [Reference Citation Analysis]
2 Zhang G, Xiao Y, Zhang X, Fan W, Zhao Y, Wu Y, Wang H, Li J. Dissecting a hypoxia-related angiogenic gene signature for predicting prognosis and immune status in hepatocellular carcinoma. Front Oncol 2022;12:978050. [DOI: 10.3389/fonc.2022.978050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Jámbor K, Koroknai V, Kiss T, Szász I, Pikó P, Balázs M. Gene Expression Patterns of Osteopontin Isoforms and Integrins in Malignant Melanoma. Pathol Oncol Res 2022;28:1610608. [DOI: 10.3389/pore.2022.1610608] [Reference Citation Analysis]
4 Kariya Y, Kariya Y. Osteopontin in Cancer: Mechanisms and Therapeutic Targets. IJTM 2022;2:419-47. [DOI: 10.3390/ijtm2030033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Catalán V, Domench P, Gómez-ambrosi J, Ramírez B, Becerril S, Mentxaka A, Rodríguez A, Valentí V, Moncada R, Baixauli J, Silva C, Escalada J, Frühbeck G. Dermatopontin Influences the Development of Obesity-Associated Colon Cancer by Changes in the Expression of Extracellular Matrix Proteins. IJMS 2022;23:9222. [DOI: 10.3390/ijms23169222] [Reference Citation Analysis]
6 Amilca-seba K, Tan TZ, Thiery J, Louadj L, Thouroude S, Bouygues A, Sabbah M, Larsen AK, Denis JA. Osteopontin (OPN/SPP1), a Mediator of Tumor Progression, Is Regulated by the Mesenchymal Transcription Factor Slug/SNAI2 in Colorectal Cancer (CRC). Cells 2022;11:1808. [DOI: 10.3390/cells11111808] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Wang M, Sun X, Xin H, Wen Z, Cheng Y. SPP1 promotes radiation resistance through JAK2/STAT3 pathway in esophageal carcinoma. Cancer Med 2022. [PMID: 35593388 DOI: 10.1002/cam4.4840] [Reference Citation Analysis]
8 Wang Z, Zhang L, Xu W, Li J, Liu Y, Zeng X, Zhong M, Zhu Y. The Multi-Omics Analysis of Key Genes Regulating EGFR-TKI Resistance, Immune Infiltration, SCLC Transformation in EGFR-Mutant NSCLC. JIR 2022;Volume 15:649-67. [DOI: 10.2147/jir.s341001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]